#Germany #Genomics #Munich #Novogene #NovaSeq X Plus

Novogene Europe Expands Sequencing Capacity

Novogene Europe has reached a significant milestone by installing its fifth Illumina NovaSeq X Plus sequencing system. This expansion aims to boost its high-throughput sequencing capabilities, essential for meeting the increasing genomic demands across Europe.

With an ever-growing interest in genomic research, Novogene Europe’s strategic enhancement positions the company as a trusted genomic partner. According to Tingting Zhou, Vice President of Novogene Europe, this investment enables the company to better serve clients’ needs with unparalleled speed and accuracy. This sizeable addition not only reflects Novogene's commitment to innovation in sequencing technology but also offers researchers exceptional data quality and cost-effectiveness in achieving scientific breakthroughs.

The NovaSeq X Plus, celebrated for its advanced sequencing capabilities, can generate up to 16 terabytes of data in just 48 hours. This robust system supports critical applications such as whole-genome sequencing, single-cell RNA analysis, and complex population studies. The substantial increase in sequencing capacity is vital as researchers globally face increasingly complex genomic questions, requiring both scale and precision in their investigations.

By incorporating an additional NovaSeq X Plus into its operational framework, Novogene Europe equips its clients with the confidence to tackle ambitious projects. The state-of-the-art technology ensures faster results while upholding data integrity and environmental responsibility.

Illumina's Bas Verhoef, Senior Vice President and Regional Director for Europe, notes the long-lasting relationship between Illumina and Novogene. He asserts that their collaboration has consistently expanded the horizons of genomics. The NovaSeq X Plus is recognized as the most rapidly adopted high-throughput sequencing platform from Illumina, offering researchers reliable, swift, and cost-effective sequencing services. Additionally, clients have expressed excitement over the enhanced capabilities brought by Novogene's recent software upgrade.

Novogene Europe has persistently integrated cutting-edge technologies into its service portfolio, including genomic, transcriptomic, microbial, and single-cell sequencing. The localized deployment within European laboratories allows for tailored support while maintaining global excellence standards. This approach proves beneficial not just in terms of technological advancement but also in fostering collaborative relationships in the research community.

About Novogene

Novogene is at the forefront of applying advanced technologies in molecular biology and high-performance computing to life sciences research. The company’s vision is to maintain its position as a global leader in providing genomic services and solutions. With one of the largest sequencing capacities worldwide, Novogene leverages its extensive scientific knowledge and top-tier customer service to assist clients in achieving their research goals in the swiftly evolving realm of genomics. Committed to being a trustworthy genomic partner, Novogene continually strives to innovate and enhance its offerings, ensuring researchers have the tools they need for success.

For more information, please contact Novogene Europe at [email protected]